BXP vs ZBIO · rev $895.7M vs rev $10.0M
Boston Properties Inc (BXP) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported BXP revenue for 2026-06-30 was $895.7M. Net income was $68.6M. Revenue was up 2.7% from 2026-03-31 to 2026-06-30. BXP currently screens at market cap $12.12B.
Latest reported ZBIO revenue for 2025-12-31 was $10.0M. Net income was -$377.7M. Revenue was up 100.0% from 2024-12-31 to 2025-12-31. ZBIO currently screens at market cap $798.0M.
BXP currently screens at market cap $12.12B. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the BXP and ZBIO stock pages for the full models.
Not investment advice.